A new trial has shown for the first time that a combination of three targeted therapies can improve survival in patients with advanced colorectal cancer with a specific mutation. The three-drug ...

Andre Fabre is considering the Dubai Sheema Classic for Sosie after his Hong Kong Vase heroics. With the exception of his ...

Over 25 years, Plansee Shanghai has been expanding its footprint in the city. In 2013, it opened its first production site, occupying more than 36,000 square meters in the Lingang area of Shanghai. An ...

From jazz and contemporary dance to immersive theatre and family musicals From music and theatre to dance and family-friendly ...

As ASCO 2025 kicks off in Chicago, pharmaphorum looks back to a conversation with Pierre Fabre Laboratories at the ESMO congress last autumn, where we spoke with experts Théodore Leondaridis, Global ...

Multiple Group 1-winning Sea The Stars colt denied familiar rival Giavellotto a repeat score and became one of a quartet of ...

By Alan Carasso & Adam Houghton Sunday's Longines Hong Kong International Races meeting at Sha Tin Racecourse attracted each of its four defending champions from 2024, and when the dust had settled on ...

Louisville Archbishop Shelton Fabre's perceived silence on immigration issues is questioned. Fabre has joined other bishops in statements on immigration and supported local immigrant-focused programs.

How would you feel if your friends abandoned you on an uninhabited island with a limited amount of food and no shelter just because you were injured? An island where wild animals lurk at night.

SECAUCUS, N.J. - Pierre Fabre Pharmaceuticals Inc. (PFP) has assumed responsibility for the Biologics License Application (BLA) for tabelecleucel from Atara Biotherapeutics Inc. (NASDAQ:ATRA), the ...

Tabelecleucel BLA currently under U.S. Food and Drug Administration (FDA) Priority Review as potentially the first approved therapy in the U.S. for EBV+ PTLD with a Prescription Drug User Fee Act ...